For the year ending 2025-12-31, RGEN made $738,256K in revenue. $98,896K in net income. Net profit margin of 13.40%.
| Income Statement | 2025-12-31 | |||
|---|---|---|---|---|
| Revenue | 738,256 | |||
| Cost of goods sold | 352,011 | |||
| Research and development | 54,177 | |||
| Selling, general and administrative | 290,508 | |||
| Change in fair value of contingent consideration | -13,607 | |||
| Total costs and operating expenses | 683,089 | |||
| Income (loss) from operations | 55,167 | |||
| Investment income | 27,574 | |||
| Interest expense | 21,513 | |||
| Loss on extinguishment of debt | 0 | |||
| Amortization of debt issuance costs | 1,660 | |||
| Other income (expense), net | 2,815 | |||
| Other income, net | 7,216 | |||
| Income before income taxes | 62,383 | |||
| Income tax provision (benefit) | 13,489 | |||
| Net (loss) income | 48,894 | |||
| Unrealized gain on available-for-sale securities, net of tax | 53 | |||
| Foreign currency translation adjustment | 49,949 | |||
| Comprehensive income (loss) | 98,896 | |||
| Basic EPS | 0.87 | |||
| Diluted EPS | 0.86 | |||
| Basic Average Shares | 56,234 | |||
| Diluted Average Shares | 56,561 | |||
REPLIGEN CORP (RGEN)
REPLIGEN CORP (RGEN)